Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results

被引：0
|
作者：
Miron A Bogdan
Hisamichi Aizawa
Yoshinosuke Fukuchi
Michiaki Mishima
Masaharu Nishimura
Masakazu Ichinose
机构：
[1] Clinica Medic Or,
[2] Kurume University,undefined
[3] Juntendo University,undefined
[4] Kyoto University,undefined
[5] Hokkaido University,undefined
[6] Wakayama Medical University,undefined
来源：
BMC Pulmonary Medicine | / 11卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Salmeterol; Formoterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results
    Bogdan, Miron A.
    Aizawa, Hisamichi
    Fukuchi, Yoshinosuke
    Mishima, Michiaki
    Nishimura, Masaharu
    Ichinose, Masakazu
    BMC PULMONARY MEDICINE, 2011, 11
  • [2] Efficacy and safety of formoterol in Japanese patients with COPD
    Minakata, Yoshiaki
    Iijima, Hideya
    Takahashi, Tsuneyuki
    Miura, Motohiko
    Ogawa, Hiromasa
    Kimura, Keiji
    Koga, Takeharu
    Kinoshita, Masaharu
    Tsuda, Tohru
    Aizawa, Hisamichi
    Ichinose, Masakazu
    INTERNAL MEDICINE, 2008, 47 (04) : 217 - 223
  • [3] Comparison of efficacy and safety of twice-daily Glycopyrronium/Formoterol combination with once-daily Glycopyrronium in patients with moderate to severe COPD
    Salvi, Sundeep
    Kumar, Anand
    Agrawal, Sumit
    Leuva, Amrutlal
    Shukla, Vineet
    Deshpande, Shrikant
    Balamurugan, Santhalingum
    Singh, Ajeet
    Tikkiwal, Sharad
    Gupta, Sandeep
    Sawant, Sandesh
    Vaidya, Abhijit
    Gogtay, Jaideep
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] AMPLIFY: A Randomized, Phase III Study Evaluating the Efficacy and Safety of Aclidinium/Formoterol Versus Monotherapy in Patients with COPD
    Sethi, S.
    Kerwin, E. M.
    Watz, H.
    Ferguson, G. T.
    Mroz, R.
    Segarra, R.
    Molins, E.
    Jarreta, D.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
    Jones, Paul W.
    Singh, Dave
    Bateman, Eric D.
    Agusti, Alvar
    Lamarca, Rosa
    de Miguel, Gonzalo
    Segarra, Rosa
    Caracta, Cynthia
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (04) : 830 - 836
  • [6] EFFICACY AND SAFETY OF ONCE-DAILY ACLIDINIUM BROMIDE 200 μG IN COMBINATION WITH FORMOTEROL IN PATIENTS WITH COPD
    Sliwinski, P.
    Perng, D-W
    Chuchalin, A.
    Jones, P. W.
    THORAX, 2010, 65 : A136 - A136
  • [7] Comparison of Efficacy and Safety of Arformoterol 15 μg Twice Daily with Arformoterol 30 μg Once Daily in Patients with COPD.
    Panettieri, R.
    Walsh, J.
    Sims, M.
    Kerwin, E.
    Fogarty, C.
    Noonan, M.
    MacIntyre, N.
    Claus, R.
    Andrews, W. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [8] The Efficacy And Safety Of Aclidinium/formoterol Fixed-Dose Combination Compared With Salmeterol/fluticasone In Patients With COPD: Results From A Phase Iii Study
    Vogelmeier, C.
    Paggiaro, P.
    Dorca, J.
    Sliwinski, P.
    Mallet, M.
    Kirsten, A. -M.
    Seoane, B.
    Segarra, R.
    Leselbaum, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] Cardiac safety of formoterol 12 μg twice daily in patients with chronic obstructive pulmonary disease
    Campbell, Sammv C.
    Criner, Gerard J.
    Levine, Bernard E.
    Simon, Stuart J.
    Smith, Jonathan S.
    Orevillo, Chadwick J.
    Ziehmer, Barbara A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (05) : 571 - 579
  • [10] Budesonide/formoterol vs formoterol, both via Turbuhaler®, in patients with moderate to severe COPD: Phase III study results
    Ichinose, Masakazu
    Samoro, Ronnie
    Fassakhov, Rustem
    Oguri, Mitsuru
    Ekelund, Jan
    Carlsson, Lars-Goran
    Fukuchi, Yoshinosuke
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345